US Patent

US8906898 — Solid forms of ceftolozane

Composition of Matter · Assigned to Calixa Therapeutics Inc · Expires 2034-05-28 · 8y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects novel solid forms of ceftolozane, along with methods for preparing and using these solid forms.

USPTO Abstract

Novel solid forms of ceftolozane are described, as well as methods for the preparation and use of these solid forms.

Drugs covered by this patent

Patent Metadata

Patent number: US8906898
Jurisdiction: US
Classification: Composition of Matter
Expires: 2034-05-28
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Calixa Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.